Clinical trial · Observational
Novel Biophotonics Methodology for Colon Cancer Screening
NCT04031963CI-TRIAL-00039734BRPcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a proposal to establish a Bioengineering Research Partnership (BRP). The major objective of the BRP is to refine and provide comprehensive, definitive multi-center validation of these novel methodologies for colorectal cancer (CRC) screening, thus providing a quantum leap in population screening.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- No treatment
- description
- Those with colon cancer and with adenomatous polyp and those without a previously mentioned condition.
Primary outcomes (1)
- measure
- Early cancer changes in the colon
- timeFrame
- Visit 1, screening colonoscopy
- description
- ELF/LEBS probe used to obtain spectroscopy readings from rectal tissue
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Subject is 18 years old or older and is having a colonoscopy procedure. Exclusion Criteria: * Concurrent usage of anticoagulation or blood thinner medication within the last 7 days that would preclude Hx of Inflammatory Bowel Disease/Colitis/Chemotherapy.
References
Publications (0)
Data not yet available
No reference posted for this study.